Literal source text
Lobbying issues and bill citations
PHA · Pharmacy
Prescription Drug Costs. H.R.1843: To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. S.1302: Increasing Transparency in Generic Drug Applications Act. H.R.1396/S.1891: Producing Incentives for Long-term Production of Lifesaving Supply of Medicine (PILLS) Act. Drug Shortages. S.1954: Biosimilar Red Tape Elimination Act. H.R.1051: To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes. American Relief Act, 2025 (PL. No: 118-158) as it relates to Patent Thickets and Q1/Q2. H.R.3955/S.2062 - RAPID Reserve Act. H.R.6992/S.1784: Mapping Americas Pharmaceutical Supply (MAPS) Act. H.R.4132/S.2027: Prescription Information Modernization Act of 2025.
Literal federal measure citations: H.R.1843, S.1302, H.R.1396, S.1891, S.1954, H.R.1051, H.R.3955, S.2062, H.R.6992, S.1784, H.R.4132, S.2027
MMM · Medicare/Medicaid
Medicare Part D Reform. S.1414: Expedited Access to Biosimilars Act. Medicaid Rebate Penalty. Medicare/Medicaid Inflation Penalties. Medicare Conditions of Participation. H.R.1: One Big Beautiful Bill Act as it relates to Delinking in Medicare Part D, Medicaid Spread Pricing, PBM transparency, and NADAC Reporting.
Literal federal measure citations: S.1414, H.R.1
CPT · Copyright/Patent/Trademark
H.R.3160/S.1553: Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act. H.R.3152/S.1546: Patent Eligibility Restoration Act of 2025. H.R.3269: Eliminating Thickets to Increase Competition (ETHIC) Act. S.1041: Affordable Prescriptions for Patients Act. S.1095: Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act. S.1096: Preserve Access to Affordable Generics and Biosimilars Act. S.43: Skinny Labels, Big Savings Act. S.1040: Drug Competition Enhancement Act. S.1097: Interagency Patent Coordination and Improvement Act of 2025.
Literal federal measure citations: H.R.3160, S.1553, H.R.3152, S.1546, H.R.3269, S.1041, S.1095, S.1096, S.43, S.1040, S.1097
TRD · Trade (domestic/foreign)
General Trade Issues. Drug Supply Chain. Country of Origin Labeling. Tariffs on Generic Medicines. Increasing Domestic Production of Generics and Biosimilars. H.R.2213/S.998: Medical Supply Chain Resiliency Act. H.R.1980: State Strategic Stockpile Act of 2025.
Literal federal measure citations: H.R.2213, S.998, H.R.1980
